Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts

In 2024, polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts trade exhibited strong growth, with global flows reaching $32,948,938,333 and a three-year compound annual growth rate of +39.9% (five-year: +31.7%). The all-time peak of $32,948,938,333 was recorded in 2024.

Over the 30-year observation window (1995–2024), 79% of years recorded positive growth, indicating a predominantly expanding market. Trend momentum is strengthening (+23.6% acceleration).

The supply side is concentrated (Herfindahl-Hirschman Index 0.382). The three largest exporters — Ireland ($18.2B), United States ($8.9B), and Denmark ($2.0B) — collectively dominate supply flows. The leading exporter has grown at +46.9% over the last three years.

On the demand side, importer concentration is concentrated (HHI 0.335). The three largest import markets are United States ($16.4B), Italy ($9.1B), and Germany ($2.3B). The largest importing market sources from 35 different supplying countries.

The dominant trade corridor is Ireland → United States at $15.3B, representing 93.0% of the importer's total demand.

The volatility score for polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts is 35 out of 100, classified as low. Trade flows are moderately variable, typical for goods with seasonal or cyclical demand patterns.

For market entrants, strong demand tailwinds create a favourable entry environment. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.